Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 2. Treatment and prevention — a secondary publication
The Ewha Medical Journal · 31.10.2024 · 47 (4)
DOI: 10.12771/emj.2024.e72 ↗Kurz gefasst
Leitlinie in der Zeitschrift The Ewha Medical Journal, online erschienen am 31.10.2024. Verfasst von Jin Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jeonbuk National University Medical School, Jeonju, Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Dermatological Association.
Abstract (Originalsprache)
Treatment should be initiated for all suspected, clinical, or confirmed cases of scabies. Patients affected should be adequately isolated, and high-risk groups with close contact histories should be treated regardless of their symptoms. Optimal treatment strategies can be selected based on age, clinical subtype, and the patient's health status. In Korea, commercially available preparations for scabies treatment include topical 5% permethrin, topical 10% crotamiton, and oral ivermectin. Topical 5% permethrin is the first-line selective treatment for both classic and crusted scabies. Alternative treatments include topical 10% crotamiton and oral ivermectin. After completing treatment, follow-up visits at 2 and 4 weeks are recommended to monitor the therapeutic response. Treatment is considered to have failed if scabies mites or burrows are detected, new clinical characteristics develop, or there is an aggravation of pruritus. Scabies itch should be adequately managed with emollients, oral antihistamines, and topical corticosteroids. Preventive measures, including personal hygiene, patient education, and environmental control, should besd implemented to reduce the transmission of scabies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Jeonbuk National University Medical School, Jeonju, Korea.
- Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
- Department of Dermatology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
- Department of Dermatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
- Department of Dermatology, Korea University Guro Hospital, Seoul, Korea.
- Department of Dermatology, Inha University Hospital, Incheon, Korea.
ORCID-Profile: Jin Park, Soon-Hyo Kwon, Young Bok Lee, Hei Sung Kim, Jie Hyun Jeon, Gwang Seong Choi
Förderung
- Korean Dermatological Association
Zitieren
APA
Park, J., Kwon, S. H., Lee, Y. B., Kim, H. S., Jeon, J. H., & Choi, G. S. (2024). Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 2. Treatment and prevention — a secondary publication. The Ewha Medical Journal, 47(4). https://doi.org/10.12771/emj.2024.e72
Vancouver
Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS. Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 2. Treatment and prevention — a secondary publication. The Ewha Medical Journal. 2024;47(4). doi:10.12771/emj.2024.e72
BibTeX
@article{Park2024,
author = {Park, Jin and Kwon, Soon-Hyo and Lee, Young Bok and Kim, Hei Sung and Jeon, Jie Hyun and Choi, Gwang Seong},
title = {Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 2. Treatment and prevention — a secondary publication},
journal = {The Ewha Medical Journal},
year = {2024},
volume = {47},
number = {4},
doi = {10.12771/emj.2024.e72}
}
EUVIMED